Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

25th Mar 2025 07:00

RNS Number : 9623B
Essentra plc
25 March 2025
 

Essentra plc (the "Company")

Director/PDMR Shareholding

The notification below, is made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

Essentra plc announces that the following Director and PDMR of Essentra plc purchased ordinary shares in the Company on 24 March 2025.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Rowan Baker

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Essentra plc

b)

 

LEI

 

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

b)

 

Nature of the transaction

 

Purchase of shares

 

c)

Price(s) and volume(s)

Volume

Price (p)

Rowan Baker

10,036

104p

d)

 

Aggregated information

- Aggregated volume

- Aggregated Price

Aggregated Volume

Aggregated Price (£)

Rowan Baker

10,036

10,438.31

e)

 

Date of the transaction 

 

24 March 2025

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

For further enquiries, please contact

Essentra plc

Emma Reid

Company Secretary

T: + 44 (0) 1908 359100

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUAGWUPAPGC

Related Shares:

Essentra
FTSE 100 Latest
Value8,658.85
Change-7.27